Droia Ventures

We are excited to share that Lawrence Van Helleputte, Associate at Droia Ventures, will be attending the upcoming PNS (Peripheral Nerve Society) Conference in Edinburgh, taking place from May 17th to 20th, 2025.   The PNS Conference brings together leading scientists, clinicians, and industry professionals dedicated to advancing research and therapies related to the peripheral nervous system.    Lawrence looks forward to engaging with innovators and researchers at the forefront of this field, exploring new scientific insights, and discussing potential opportunities for collaboration. If you’re attending the conference and would like to connect, feel free to reach out Lawrence Van Helleputte!   #PNS2025 #PeripheralNeuropathy #Symposium #GrowingTogether

 We are pleased to announce that our colleagues Matthias Van Woensel, Partner at Droia Ventures and Mathias Declercq, Senior Associate, will be attending the prestigious AACR 2025, American Association for Cancer Research, Chicago next month. ✨ Looking ahead to AACR 2025 – where science meets impact! Let’s push the boundaries of innovation — together. 💡🧬 #CancerResearch #Innovation #Collaboration #AACR2025 #AACR #cancer #cancerresearch #drugdevelopment #healthcare

We are pleased to introduce Hillstar Bio, a pioneering biotechnology company dedicated to transforming the treatment of autoimmune diseases. Today, we launched with a  $67 million Series A financing led by a syndicate of experienced investors and shareholders from the U.S., Europe, and Asia, including Droia Ventures, Frazier Life Sciences, Novo Holdings, LifeArc Ventures, and Hummingbird Bioscience. Developed by a world-class team of experts, Hillstar’s approach targets and depletes pathogenic immune cells while preserving healthy ones. We aim to reset the immune system and provide patients with durable therapeutic responses, potentially reducing the need for long-term immunosuppressive treatments. Learn more about Hillstar Bio here: https://bit.ly/4iYfiBi #hillstarbio #precisionimmunotherapy #precisionimmunology #autoimmunedisease #immunology #trbv9 #invisibleillness #chronicillness #axspa

🌟 Another proud moment at Droia Labs / Metaptys! 🌟 We’re thrilled to share that Kathleen Sonck has been promoted to Principal Scientist! Since joining us in 2022, Kathleen Sonck has stood out through her independence, quick grasp of complex topics, and her consistently positive and proactive mindset. No task is ever too small, she tackles everything with energy and a can-do attitude. This promotion is a reflection of her outstanding contribution to the team and her continued growth as a scientist and leader. Huge congratulations, Kathleen Sonck — here’s to the next chapter! 🚀👏 #TeamMetaptys #DroiaLabs #LifeSciences #Promotion #Leadership #ScientificExcellence #WomenInSTEM

🎉 Exciting news from Droia Labs / Metaptys! 🎉 We’re proud to announce the promotion of Katleen Brepoels to Senior Technician! Katleen has been with us since the very beginning of Droia Labs in 2022, and her journey has been nothing short of impressive. Her growing independence and initiative in taking on valuable and complex research projects have truly set her apart. This new title is a well-deserved recognition of her dedication, expertise, and continuous growth. Congratulations, Katleen Brepoels — we’re lucky to have you on the team! 👏 #TeamMetaptys #DroiaLabs #LifeSciences #Promotion #CareerGrowth #Gratitude #Teamwork

Mathias De Decker, our Senior Scientific Analyst at Droia, will be attending the prestigious Annual International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) 🧠💡 in Vienna 🇦🇹, taking place from April 1-5. The AD/PD conference is a key event in the field of neurodegenerative diseases, bringing together leading experts, researchers, and professionals with a shared goal of striving for a better future for those affected by Alzheimer’s, Parkinson’s, and related neurological disorders. Mathias is eager to connect 🤝, exchange insights 📚, and contribute 🔍 to the ongoing efforts to combat these diseases. We are excited for the valuable insights that will emerge from this important gathering and look forward to the continued progress in the fight against neurodegenerative disorders! 🚀🌍 #ADPD2025 #Neuroscience #Innovation

We are thrilled to share that as of March 1st, Dieter Petit, PhD Petit has been promoted to Senior Associate! 🎉 Dieter has been an invaluable member of our team, bringing sharp insights, dedication, and a true passion for science. His contributions have been instrumental in driving Droia’s mission forward! Congratulations, Dieter! Well deserved! 👏 #DroiaVentures #Promotion #TeamGrowth #BiotechInvesting

Thrilled to announce that our Associate, Dieter Petit, PhD will attend @BioEurope Spring 2025 in Milan from March 17-19! 🇮🇹✨ This event is always a great opportunity to connect with fellow investors, pharma leaders, and biotech innovators, exchanging insights on the latest industry trends and opportunities. If you’re attending, let’s connect on-site and explore ways to collaborate! 🤝 #BioEuropeSpring #Biotech #Pharma #Investment #Networking #LifeSciences #Milan2025

We’re thrilled to announce that Luc Dochez, our Managing Partner Genetic Diseases at Droia Ventures, will be joining the East - West BioPharma Summit in Singapore, organized by BioCentury Inc.! 🌏🔬 Luc will be a panelist in the Capital Markets Showcase, where top investors will discuss how biotechs in the East and West can navigate the challenges of a prolonged bear market and position themselves to attract investment. While the global biotech ecosystem shares common hurdles, each region faces unique challenges—making it critical for biotech leaders to understand their landscapes and adapt in a rapidly evolving environment. 💡 How can biotechs rise above the noise and secure the funding they need? Join the discussion to find out! 📅 Date: Tuesday, March 4, 2025 ⏰ Time: 10:00 AM – 10:45 AM 📍 Location: ParkRoyal Collection Marina Bay, Singapore Looking forward to insightful conversations and meaningful connections at this prestigious event! If you’ll be there, let’s connect. 🤝 #DroiaVentures #Biotech #Investment #CapitalMarkets #EastWestBioPharma #BioCentury #BiotechFunding

Exciting News! 📰 We’re thrilled to share that our company creation Alesta Therapeutics has successfully raised €65 million in Series A financing to propel the development of innovative oral small molecule treatments for rare diseases. This milestone brings us closer to transforming the lives of patients who are often overlooked. Read more about this breakthrough achievement here! #Innovation #RareDiseases #Biotech https://lnkd.in/er94ddQZ